REQUEST A DEMO
Total
USD $0.00
Search more companies

Vemax011 Pharma D.O.O. Beograd-Vozdovac (Serbia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Vemax011 Pharma D.O.O. Beograd-Vozdovac Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Vemax011 Pharma D.O.O. Beograd-Vozdovac is an enterprise located in Serbia, with the main office in Belgrade. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. Vemax011 Pharma D.O.O. Beograd-Vozdovac was incorporated on March 10, 2026. There are currently 34 (2023) people employed by Vemax011 Pharma D.O.O. Beograd-Vozdovac. In its most recent financial highlights, the company reported a net sales revenue increase of 46.15% in 2024. Over the same period, its total assets grew by 54.29%. The net profit margin of Vemax011 Pharma D.O.O. Beograd-Vozdovac increased by 0.11% in 2024.

Headquarters
Mosorska 9
Belgrade; Belgrade;

Contact Details: Purchase the Vemax011 Pharma D.O.O. Beograd-Vozdovac report to view the information.

Basic Information
Total Employees:
Purchase the Vemax011 Pharma D.O.O. Beograd-Vozdovac report to view the information.
Registered Capital:
Purchase the Vemax011 Pharma D.O.O. Beograd-Vozdovac report to view the information.
Financial Auditors:
Purchase the Vemax011 Pharma D.O.O. Beograd-Vozdovac report to view the information.
Incorporation Date:
March 10, 2026
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Subsidiaries
Vemax Shop
100%
Company Performance
Financial values in the chart are available after Vemax011 Pharma D.O.O. Beograd-Vozdovac report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
46.15%
Total operating revenue
45.78%
Operating Profit/Loss (EBIT)
48.72%
EBITDA
48.56%
Net Profit/Loss for the Period
47.23%
Total Assets
54.29%
Total Equity
56.79%
Operating Profit Margin (ROS)
0.33%
Net Profit Margin
0.11%
Return on Equity (ROE)
-5.47%
Debt/Equity
1.77%
Quick Ratio
-0.27%
Cash Ratio
-0.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?